Moreover, clinical data tempered the “2-hits only” hypothesis because AML is uncommon (∼5% of associated malignancies) in patients with Li-Fraumeni syndrome associated with germline TP53 mutations [17, 18]. The gene discussed is TP53; the disease is acute myeloid leukemia.